Cargando…
Anti–glomerular basement membrane disease during the COVID-19 pandemic
Autores principales: | Prendecki, Maria, Clarke, Candice, Cairns, Tom, Cook, Terry, Roufosse, Candice, Thomas, David, Willicombe, Michelle, Pusey, Charles D., McAdoo, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318989/ https://www.ncbi.nlm.nih.gov/pubmed/32599088 http://dx.doi.org/10.1016/j.kint.2020.06.009 |
Ejemplares similares
-
Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization
por: Tempest-Roe, Shenzhen, et al.
Publicado: (2022) -
Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohort
por: Navaratnarajah, Arunraj, et al.
Publicado: (2019) -
COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021) -
Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease
por: Turner-Stokes, Tabitha, et al.
Publicado: (2021) -
SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
por: Prendecki, Maria, et al.
Publicado: (2020)